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THE PATIENT SELF-DETERMINATION ACT OF
1990: HEALTH CARE'S OWN MIRANDA
Birth and death are the most singular events we experience and,
therefore, the contemplation of death should be a thing of beauty
and not of ignobility.'
By 1985, only fifteen percent of the population had written advance direc-
tives2 pertaining to future health care decision-making.3 These advance di-
rectives take several forms, with the most limited being the living will.4
Living wills allow individuals, prior to incompetency, to dictate the specific
treatments they would accept under certain situations and conditions. 5 Liv-
ing will statutes, however, are often limited to situations when death is immi-
nent, and therefore, the statutes do not protect patients from all unwanted
treatment.6 Living wills may be used to request treatment as well as refuse
1. HOUSE SELECT COMM. ON AGING, 99TH CONG., IST SEss., DYING WITH DIGNITY:
DIFFICULT TIMES, DIFFICULT CHOICES 5-6 (Comm. Print 1985) (statement of former Senator
Jacob Javits (R-N.Y.)).
2. Advance directives may be broadly defined as "any statement made by an individual,
while competent, of the individual's preferences for any treatment decision, or for the process
of decision-making, in the event the person loses the ability to make decisions." AMERICAN
BAR ASS'N, COMM'N ON LEGAL PROBLEMS OF THE ELDERLY, PATIENT SELF-DETERMINA-
TION ACT STATE LAW GUIDE 16 (1991) [hereinafter A.B.A. COMMISSION]. The Patient Self-
Determination Act (PSDA), however, narrows this general definition to any "written instruc-
tion, such as a living will or durable power of attorney for health care, recognized under State
law (whether statutory or as recognized by the courts of the State) and relating to the provision
of... [health] care when the individual is incapacitated." Pub. L. No. 101-508, §§ 4206(a),
4751(m), 104 Stat. 1388-116, 1388-205 (1990) (to be codified at 42 U.S.C. §§ 1395, 1396).
Accordingly, informal instructions made orally by individuals to doctors, family, or friends are
not promoted by PSDA.
3. See Fiscal Year 1991 Reconciliation Issues Relating to Durable Medical Equipment,
Clinical Laboratory Services, and Other Issues Under the Medicare Program: Hearing Before
the Subcomm. On Health of the Comm. on Ways and Means, 101st Cong., 2nd Sess. 81-82
(1990) [hereinafter Reconciliation Issues Hearing] (statement of Ezekiel J. Emanuel, M.D.,
Ph.D., Harvard University Medical School). Dr. Emanuel based his estimate on a study con-
ducted in 1985. The study found that despite the fact that 90% of patients and the general
public desire advance directives, only 15% actively completed a document, appointed a proxy,
or had a formal discussion of terminal care decisions with their physician. Id. Another study
found that between 4% and 17.5% of adults have completed an advance directive. John La
Puma et. al., Advance Directives on Admission: Clinical Implications and Analysis of the Patient
Self-Determination Act of 1990, 266 JAMA 402, 402 (1991).
4. See generally, David Orentlicher, Advance Medical Directives, 263 JAMA 2365, 2365-
66 (1990).
5. Id. at 2365.
6. Id. See, e.g., ILL. ANN. STAT. ch. 110 1/2, para. 702 (Smith-Hurd Supp. 1991) (stat-
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it,7 but state law dictates the terms of the document,8 thereby limiting its
scope.9 The documents' primary deficiency is that in many instances the
living will fails to guide families or medical providers, who wish to consider
the patient's interests regarding treatment.1°
Another form of advance directive allows individuals to designate a proxy
who may be authorized to make health care decisions when events occur
that are outside the specific conditions stated in the living will document or
in a health care durable power of attorney.l" A health care power of attor-
ney is a relatively new variation of the traditional durable power of attorney
forms, used solely to appoint proxies for property management and transac-
tions. 2 Due to the existence of traditional power of attorneys, there is much
debate among courts as to whether separate health care power of attorney
forms are necessary.' 3 Those opposed to their use are concerned that the
forms may be too ambiguous and therefore inadequate absent the expressed
statutory language delegating medical decision-making powers.' 4
Although legislators and scholars acknowledge the increasing usefulness
and benefits of advance directives, the majority of the general public fails to
ing that nutrition and hydration shall not be withdrawn if the withdrawal would result in
death solely from dehydration or starvation rather than from the existing terminal condition).
7. Tamar Lewin, Led By Court, Hospitals Take New Interest in Living Wills, N.Y.
TIMES, July 23, 1990, at Al.
8. See A.B.A. COMMISSION, supra note 2, at 17.
9. Living Wills: Hearings on S. 1766 Before the Subcomm. On Medicare and Long Term
Care of the Committee on Finance, United States Senate, 101st Cong., 2d Sess. 161 (1990)
[hereinafter Living Wills Hearings] (statement of the National Legal Center for the Medically
Dependent & Disabled, Inc.).
10. See, e.g., Elisabeth Rosenthal, Filling the Gap Where a Living Will Won't Do, N.Y.
TIMES, Jan. 17, 1991, at B9.
11. Living Wills Hearings, supra note 9, at 41 (statement of Charles Sabatino, Assistant
Director, ABA Commission on Legal Problems of the Elderly of the ABA). But see The
Choice of Not Living a Vegetative Life; Power of Attorney, N.Y. TIMES, Dec. 23, 1990, at ElO
(letter to the editor by Mary K. Goldstein discussing the pitfalls of the durable power of attor-
ney laws). In addition to generally worded power of attorney forms, some commentators ad-
vocate a checklist type form or a "values history" type form to determine a declarant's view on
quality of life. See, e.g., Linda L. Emanuel & Ezekiel J. Emanuel, The Medical Directive: A
New Comprehensive Advance Care Document, 261 JAMA 3288 (1989). For a list of the state
statutes, see infra note 57.
12. See A.B.A. COMMISSION, supra note 2, at 19.
13. See, e.g., In re Peter, 529 A.2d 419, 426 (N.J. 1987) (stating that New Jersey's general
power of attorney statute specifically authorizes conveyance of durable authority to make med-
ical decisions). Additionally, in Cruzan v. Director, Mo. Dep't of Health, Justice Sandra Day
O'Connor argued that use of the state's general power of attorney as a "procedure[] for surro-
gate decisionmaking ... may be a valuable additional safeguard of the patient's interest in
directing his medical care." 110 S. Ct. 2841, 2857 (1990) (O'Connor, J., concurring).
14. See A.B.A. COMMISSION, supra note 2, at 19.
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benefit from these statutes. The Patient Self-Determination Act of 19905
(PSDA) attempts to promote the use of advance directives by increasing
public awareness about them. The critics argue that the PSDA's goals can-
not be achieved by such a simple measure,16 while the statute's supporters
find merit in the PSDA's unique ability to compel states to work for in-
creased awareness of their various advance directive statutes by threatening
them with the loss of Medicare and Medicaid funding.17 This Commentary
briefly discusses the PSDA's historical setting and essential components.
Next, it explains and responds to the arguments of the statute's critics and
discusses the reasons why the PSDA should be endorsed. Finally, this Com-
mentary concludes by suggesting that, in time, the PSDA will be a signifi-
cant and effective initial piece of legislation promoting the use of advance
directives and allowing individuals to control health care decision-making.
I. ACTIONS LEADING UP TO THE PSDA's PASSAGE
In the time between the PSDA's enactment 8 and its effective date, 9 a
book called Final Exit,2° which discusses various methods of suicide, became
a bestseller. 2 The book reflects the public's ever-increasing interest in self-
determination.22 This interest results from the advances in medical technol-
ogy which make it possible to keep patients alive by artificial and technologi-
cal means.2 3 It also stems from highly publicized cases over the past fifteen
years involving incompetent patients such as Karen Ann Quinlan24 and
Nancy Beth Cruzan.25
Medical technology has advanced so dramatically that eighty percent of
the reported daily deaths in America are individuals who have been depen-
15. §§ 4206, 4751, 104 Stat. at 1388-115, 1388-205.
16. See infra notes 74-113 and accompanying text.
17. See infra notes 114-130 and accompanying text.
18. President Bush signed the PSDA into law on November 5, 1990. § 4206, 104 Stat. at
1388-115.
19. The PSDA went into effect on Dec. 1, 1991. § 4206, 104 Stat. at 1388-117.
20. DEREK HUMPHRY, FINAL EXIT (1991).
21. Best Sellers, WASH. POST, Oct. 27, 1991, (Book World), at 13.
22. For other examples of the public's interest, see Joyce Price, Suicide Initiative Vote
Shows Changing Mood, WASH. TIMEs, Nov. 7, 1991, at A3 (referring to Washington State's
failed referendum legalizing euthanasia); Isabel Wilkerson, Opponents Weigh Action Against
Doctor Who Aided Suicides, N.Y. TIMEs, Oct. 25, 1991, at AI0 (referring to use of a "suicide
machine" by Dr. Jack Kevorkian on critically ill patients).
23. See infra notes 26-29 and accompanying text.
24. See In re Quinlan, 355 A.2d 647 (N.J. 1976), cert. denied, 429 U.S. 922 (1976).
25. Cruzan v. Director, Mo. Dep't of Health, 110 S. Ct. 2841, 2841 (1990). See John K.
Gisleson, Commentary, Right To Die, Forced To Live: Cruzan v. Director, Missouri Depart-
ment of Health, 7 J. CONTEMP. HEALTH L. & POL'Y 401 (1991).
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dent on respiratory ventilation or artificial tube feeding and hydration.26 In-
deed, bodily functions may now be sustained long after many believe the
patient is dead.27 This statistic represents a dramatic change from 1939,
when just over one-third of the population died in institutional settings such
as hospitals and nursing homes.2" Additionally, about eighty percent of the
deaths in American institutions occur subsequent to decisions by the patient,
family, or medical staff, either individually or collectively, to apply, with-
hold, or withdraw a medical procedure.29
In 1976, as developments in medical technology forced new interpreta-
tions of the definitions of death, the case of Karen Ann Quinlan demon-
strated the inadequacy of laws that failed to respond to rapid technological
advancement. 30 Karen Ann Quinlan was a twenty-two-year-old comatose
patient completely dependent upon a respirator which maintained her in a
"chronic persistent vegetative state" for an entire year prior to litigation.31
Her family urged the court to order the withdrawal of the life support appa-
ratus. The New Jersey Supreme Court ultimately granted the family's re-
quest upon the concurrence of her guardian, her attending physicians, and
the hospital's ethics committee. 32 Recognizing that the parents believed that
their daughter would have refused treatment if capable, the court deter-
mined that the right to privacy in choosing medical treatment-and the ex-
tent of bodily intrusion-should not be discarded merely because the patient
is incapable of exercising her rights.33
Quinlan put New Jersey at the forefront of an ethical and legal dilemma
concerning incompetent patients who do not have advance directives or the
26. Andrew H. Malcolm, A.M.A. Rule: Step Toward A Social Policy on Dying, N.Y.
TIMEs, Mar. 17, 1986, at B7. See 136 CONG. REC. E943 (daily ed. Apr. 3, 1990) (statement of
Rep. Sander Levin (D-Mich)). See also George P. Smith, II, All's Well That Ends Well: To-
ward a Policy of Assisted Rational Suicide or Merely Enlightened Self-Determination?, 22 U.C.
DAvis L. REV. 275, 367 (1989); George P. Smith, II, Death Be Not Proud: Medical, Ethical
and Legal Dilemmas in Resource Allocation, 3 J. CONTEMP. HEALTH L. & POL'Y 47, 51
(1987).
27. 135 CONG. REC. S13,573 (daily ed. Oct. 17, 1989) (statement of Myra J. Christopher,
Midwest Bioethics Center).
28. 136 CONG. REC., supra note 26, at E943 (statement of Rep. Levin).
29. Id. For a general discussion of the removal of nutrient feeding tubes, see Scott E.
Squillace, Comment, Removal of a Nutrient Feeding Tube and the Need for a Living Will, 3 J.
CONTEMP. HEALTH L. & POL'Y 253 (1987).
30. In re Quinlan, 355 A.2d 647, 656 (N.J. 1976), cert. denied, 429 U.S. 922 (1976).
31. Id. at 654.
32. Id. at 671. The court found that "there is no reasonable possibility of Karen's ever
emerging from her present comatose condition to a cognitive, sapient state." Id. at 671.
33. Id. at 664.
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legal option of executing them.3 4 This dilemma plagued New Jersey and
other courts throughout the country.35 Later, the same New Jersey court
that decided Quinlan faced similar issues in the case of In re Conroy.36
Rather than removal of a respirator, In re Conroy involved removal of a
feeding tube.37 Analogizing between intravenous nourishment and respira-
tory assistance, the court ordered removal after applying three separate
tests.38 The tests allowed withdrawal of treatment if there was trustworthy
evidence that the patient would have refused treatment, or if there was evi-
dence of refusal, or if pain and suffering outweighed the benefits that the
patient derived from life.39
New Jersey was not alone in facing the need for advance directives. In
1988, for example, a New York court rejected the request of a stroke victim's
family by ordering the insertion of a feeding tube into a seventy-seven-year-
old patient and refusing to "substitute its judgment as to what would be
acceptable quality of life for another."'  That same year, a California court
held that a patient's conservator could exercise a patient's constitutional and
common-law rights to refuse treatment if the decision was made in good
faith and if medical experts decided that treatment was necessary. 1
The prevalence of cases involving incompetent patients who had either
lost their right to self-determination or had that right severely scrutinized
demonstrated a need to increase public awareness about advance directives
and further emphasized the need for the enactment of the PSDA.42 Unfor-
tunately, despite rapid technological advancement and the increasing
number of controversial cases, concerns over the PSDA's potential lack of
effectiveness prevented the original 1989 version of the PSDA from making
34. For a brief discussion of New Jersey's role, see Steele Chadwell, Cruzan Ruling Settles
Issues, Raises Others, 126 N.J. L.J. 10 (1990).
35. Id. See infra notes 36-48 and accompanying text.
36. 486 A.2d 1209 (N.J. 1985).
37. Id.
38. Id. at 1231-33.
39. Id.
40. In re Westchester County Medical Ctr., 531 N.E.2d 607, 613 (N.Y. 1988).
41. Drabick v. Drabick, 245 Cal. Rptr. 840, 849 (Ct. App. 1988), cert. denied, 488 U.S.
958 (1988).
42. See, e.g., Gray v. Romeo, 697 F. Supp. 580 (D. R.I. 1988); Bouvia v. Superior Court,
225 Cal. Rptr. 297 (1986); McConnell v. Beverly Enterprises-Conn., 553 A.2d 596 (Conn.
1989); Foody v. Manchester Memorial Hosp., 482 A.2d 713 (Conn. Super. Ct. 1984); In re
Estate of Longeway, 549 N.E.2d 292 (Ill. 1989); Brophy v. New England Sinai Hosp., Inc.,
497 N.E.2d 626 (Mass. 1986); In re Grant, 747 P.2d 445 (Wash. 1987); In re Hamlin, 689 P.2d
1372 (Wash. 1984). For a discussion of one family's amazing but probably not atypical plight,
see Living Wills Hearings, supra note 9, at 91-101 (statement of Julianne Delio). See generally
Michael L. Daily, Administrative Comment, Euthanasia in Maryland: The Right to Die With
Dignity?, 5 J. CONTEMP. HEALTH L. & POL'Y 297 (1989).
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it out of committee before the Congress adjourned.43
The Supreme Court's 1990 decision in Cruzan v. Director, Missouri De-
partment of Health" turned the enactment of the PSDA bill into a compel-
ling mandate.45 Similar to earlier cases, Cruzan involved an incompetent
patient who had not executed an advance directive.46 In this precedential
decision, the majority of the Court recognized the right to die.4 7 However,
the Court held that the state's interest in the protection of life absent a living
will allows it to "apply a clear and convincing evidence standard in proceed-
ings where a guardian seeks to discontinue nutrition and hydration of a per-
son diagnosed to be in a persistent vegetative state.",4' The clear and
convincing evidence standard makes it more difficult for a family to refuse
unwanted treatment and makes the use of advance directives all the more
essential.
Following the Cruzan decision, Senator John Danforth (R-Mo.), a mem-
ber of the Senate Finance Committee, attached the PSDA to the Omnibus
Budget Reconciliation Act (OBRA).49 The President signed the acts into
law on November 5, 1990.5o
II. THE PSDA's ESSENTIAL COMPONENTS
The PSDA is the first significant federal legislation concerning the use of
advance directives to control health care treatment and decisions.5" The
purpose of the PSDA is to inform the public about and increase the use of
these advance directives.5 2 To achieve these objectives, the PSDA assigns
specific functions to the states,53 to any organization eligible for Medicare or
Medicaid,5 4 and to the Department of Health and Human Services.55
43. Keith White, Budget Bill Contains Medical Rights Measure, Gannett News Service,
Oct. 29, 1990, available in LEXIS, Nexis Library, Omni File.
44. 110 S. Ct. 2841 (1990).
45. Living Wills Get Boost From the Lawmakers, NAT'L L.J., Oct. 29, 1990, at 33; see also
136 CONG. REC. H4,222 (daily ed. June 27, 1990) (statement of Rep. Levin).
46. Cruzan, 110 S. Ct. 2841, 2846.
47. The majority agreed that, at the very least, the Due Process Clause provides a consti-
tutional right to die by refusing life-sustaining medical treatment. Id. at 2853. However, Jus-
tice Sandra Day O'Connor stated more explicitly in her concurrence that "the liberty
guaranteed by the Due Process Clause must protect, if it protects anything, an individual's
deeply personal decision to reject medical treatment, including the artificial delivery of food
and water." Id. at 2857.
48. Id. at 2854.
49. White, supra note 43.
50. A.B.A. COMMISSION, supra note 2, at 3.
51. Id. at 1; See §§ 4206, 4751, 104 Stat. at 1388-115, 1388-204.
52. 136 CONG. REC. E2,190 (daily ed. June 28, 1990) (statement of Rep. Levin).
53. § 4751(a), 104 Stat. at 1388-204.
54. § 4206(a), 104 Stat. at 1388-115.
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Under the PSDA, each state must develop a written description of its stat-
utory or judicial law concerning advance directives for dissemination and
use by health care providers.56 This type of law exists in some form in the
vast majority of states." In addition to developing written descriptions,
states must ensure that each health care provider receiving Medicare or
55. § 4751(d), 104 Stat. at 1388-205.
56. § 4751(a), 104 Stat. at 1388-204.
57. At least forty states have living will statutes: ALA. CODE §§ 22-8A-1 to -10 (1975);
ALASKA STAT. §§ 18.12.010-.12.100 (1991); ARIZ. REV. STAT. ANN. §§ 36-3201 to -3211
(1986 & Supp. 1991); ARK. CODE ANN. §§ 20-17-201 to -218 (Michie 1991); CAL. HEALTH &
SAFETY CODE §§ 7185-7194 (West Supp. 1992); COLO. REV. STAT. §§ 15-18-101 to -113
(1987 & Supp. 1991); CONN. GEN. STAT. ANN. §§ 19a-570 to -575 (West Supp. 1990); DEL.
CODE ANN. tit. 16, §§ 2501-2508 (1983); D.C. CODE ANN. §§ 6-2421 to -2430 (1989); FLA.
STAT. ANN. §§ 765.01-.15 (West 1986 & Supp. 1992); GA. CODE ANN. §§ 31-32-1 to -12
(Michie 1991); HAW. REV. STAT. §§ 327D-1 to -27 (1991); IDAHO CODE §§ 39-4501 to -4508
(1985 & Supp. 1991); ILL. ANN. STAT. ch. 110 1/2, para. 701-710 (Smith-Hurd Supp. 1991);
IND. CODE ANN. § 16-8-11-1 (Burns 1990); IOWA CODE ANN. §§ 144A.1-.11 (West 1989);
KY. REV. STAT. ANN. §§ 311.622-.644 (Michie/Bobbs-Merrill Supp. 1990); LA. REV. STAT.
ANN. §§ 40:1299:58.1-.10 (West Supp. 1991); ME. REV. STAT. ANN. tit. 18A, §§ 5-701 to -714
(West Supp. 1991); MD. HEALTH-GEN. CODE ANN. §§ 5-601 to -614 (1990); MINN. STAT.
ANN. §§ 145B-.01-.17 (West Supp. 1992); MISS. CODE ANN. §§ 41-41-101 to -121 (Supp.
1991); Mo. ANN. STAT. §§ 459.010-055 (Vernon Supp. 1992); MONT. CODE ANN. §§ 50-9-
101 to -206 (1991); NEV. REV. STAT. ANN. §§ 449.535-.760 (Michie 1991); N.H. REV. STAT.
ANN. §§ 137-H:1 to -H:16 (Supp. 1991); N.M. STAT. ANN. §§ 24-7-1 to -11 (Michie 1991);
N.C. GEN. STAT. §§ 90-320 to -323 (1990 & Supp. 1991); N.D. CENT. CODE §§ 23-06.4 to -.4-
14 (1991); OR. REV. STAT. §§ 127.605-650 (1991); R.I. GEN. LAWS §§ 23-4.11 to -9 (Supp.
1991); S.C. CODE ANN. §§ 44-77-10 to -160 (Law. Co-op. Supp. 1991); TENN. CODE ANN.
§§ 32-11-101 to -112 (Supp. 1991); TEX. HEALTH & SAFETY CODE ANN. §§ 672.001-.021
(West Supp. 1991); UTAH CODE ANN. § 75-2-1101-75 to -1118 (Supp. 1991); VT. STAT. ANN.
tit. 18, §§ 5251-5262 (1987); VA. CODE ANN. §§ 54.1-2981 to -2992 (Michie 1991); W. VA.
CODE §§ 16-30-1 to -10 (1985 & Supp. 1991); WIS. STAT. ANN. §§ 154.01-.15 (West 1989);
WYO. STAT. §§ 35-22-101 to -108 (1988).
At least thirty states provide for health care powers of attorney: ARK. CODE ANN. § 20-17-
202 (Michie 1991); CAL. CIV. CODE §§ 2430-2438 (West Supp. 1992); DEL. CODE ANN. tit.
16, § 2502 (1983); D.C. CODE ANN. §§ 21-2201 to -2213 (1989); FLA. STAT. ANN.
§§ 745.41.52 (West Supp. 1992); GA. CODE ANN. §§ 31-36-1 to -13 (Michie 1991); IDAHO
CODE § 39-4505 (1991); ILL. ANN. STAT. ch. 110 1/2, para. 804-1 to -12 (Smith-Hurd Supp.
1991); IND. CODE ANN. §§ 16.8-12-5 to -12-8 (Burns 1990); IOWA CODE ANN. § 144A.7(l)(a)
(West 1989); KAN. STAT. ANN. § 58-632 (Supp. 1989); Ky. REV. STAT. ANN. §§ 311.970-.990
(Michie/Bobbs Merrill Supp. 1990); LA. REV. STAT. ANN. §§ 40:1299.58.1-.58.10 (West
Supp. 1991); ME. REV. STAT. ANN. tit. 18-A, § 5-501 (West Supp. 1991); MINN. STAT. ANN.
§ 145B.03 (West Supp. 1992); MIss. CODE ANN. § 41-41-151 (Supp. 1990); MONT. CODE
ANN. § 50-9-103 (1991); N.H. REV. STAT. ANN. §§ 137-J:1 to -J:16 (Supp. 1991); NEV. REV.
STAT. ANN. §§ 449.613-.860 (Michie 1991); OHIO REV. CODE ANN. §§ 1337.11-.17 (Ander-
son Supp. 1990); OR. REV. STAT. § 127.505-585 (1991); R.I. GEN. LAWS § 23-4.10-1 (1989);
S.D. CODIFIED LAWS ANN. § 59-7-2.5 (Supp. 1990); TENN. CODE ANN. §§ 34-6-202-215
(Supp. 1991); UTAH CODE ANN. § 75-2-1106 (Supp. 1991); VT. STAT. ANN. tit. 14, §§ 3453-
3467 (1989 & Supp. 1991); VA. CODE. ANN. § 54.1-2984 (1991); WASH. REV. CODE ANN.
§ 11.94.046 (West Supp. 1990); W.VA. CODE §§ 16-30A-3 to -20 (Supp. 1991); WYO. STAT.
§ 35-22-102 (1988).
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Medicaid funds complies with the duties imposed on them by the PSDA. 58
Health care organizations, including hospitals, skilled nursing facilities,
home health agencies, and hospice programs, where approximately eighty
percent of all individuals die, have more extensive duties under the PSDA.59
First, any organization receiving Medicare or Medicaid funding must pro-
vide the advance directive descriptions to adult individuals admitted as pa-
tients, residents,' or those receiving hospice care.6 1 Second, these health
care providers must formulate written policies to implement the state's
58. § 4751(a), 104 Stat. at 1388-204.
59. 136 CONG. REC., supra note 26, at E943 (statement of Rep. Levin). But see 135
CONG. REC., supra note 27, at S13,566 (statement of Sen. John Danforth (R-Mo.)) (estimating
that 75% of all deaths occur in hospitals and medical centers). Rep. Levin probably bases his
80% figure on a study conducted by the President's Commission for the Study of Ethical
Problems in Medicine. See PRESIDENT'S COMM'N FOR THE STUDY OF ETHICAL PROBLEMS
IN MEDICINE AND BIOMEDICAL AND BEHAVIORAL RESEARCH, DECIDING TO FOREGO LIFE-
SUSTAINING TREATMENT: A REPORT ON THE ETHICAL, MEDICAL, AND LEGAL ISSUES IN
TREATMENT DECISIONS 16-18 (1983).
60. § 4206(a), 104 Stat. at 1388-116.
61. Id. Eligible organizations must also follow these procedures. The term "Eligible or-
ganization" is defined in 42 U.S.C. § 1395mm(b) as:
[A] public or private entity (which may be a health maintenance organization or a
competitive medical plan), organized under the laws of any State, which-
(1) is a qualified health maintenance organization (as defined in section 1310(d) of
the Public Health Service Act [42 U.S.C.S. § 300e-9(d)], or
(2) meets the following requirements:
(A) The entity provides to enrolled members at least the following health
care services:
(i) Physicians' services performed by physicians (as defined in section
1861(r)(1) [42 U.S.C.S. § 1395x(r)(1)]).
(ii) Inpatient hospital services.
(iii) Laboratory, X-ray, emergency, and preventive services.
(iv) Out-of-area coverage.
(B) The entity is compensated (except for deductibles, coinsurance, and
copayments) for the provision of health care services to enrolled members by a pay-
ment which is paid on a periodic basis without regard to the date the health care
services are provided and which is fixed without regard to the frequency, extent, or
kind of health care service actually provided to a member.
(C) The entity provides physicians' services primarily (i) directly through
physicians who are either employees or partners of such organization, or (ii) through
contracts with individual physicians or one or more groups of physicians (organized
on a group practice or individual practice basis).
(D) The entity assumes full financial risk on a prospective basis for the
provision of the health care services listed in subparagraph (A), except that such
entity may-
(i) obtain insurance or make other arrangements for the cost of pro-
viding to any enrolled member health care services listed in subparagraph (A) the
aggregate value of which exceed $5,000 in any year,
(ii) obtain insurance or make other arrangement for the cost of health
care service listed in subparagraph (A) provided to its enrolled members other than
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guidelines concerning advance directives62 and inform patients about these
policies.63 Health care organizations must document in each individual's
medical record whether an advance directive has been executed, 6' and, if so,
ensure that it complies with the state developed description.65
In addition, health care providers must develop educational programs for
the organizations' staff and the community it serves on issues concerning
advance directives.66 Finally, these organizations are prohibited from plac-
ing conditions on the provision of care or otherwise discriminating against
patients based on whether they have executed an advance directive. 67 Fail-
ure by any organization to follow the PSDA's mandates may result in the
loss of federal Medicare and Medicaid funding.68
Complementing the mandates of the state and provider organizations, the
Department of Health and Human Services (DHHS) is required to under-
take a national educational campaign by June 1, 1992.69 The campaign is
designed "to inform the public of the option to execute advance directives
and of a patient's right to participate and direct health care decisions."70
The DHHS is also responsible for developing materials to be distributed by
through the entity because medical necessity required their provision before they
could be secured through the entity,
(iii) obtain insurance or make other arrangements for not more than
90 percent of the amount by which its costs for any of its fiscal years exceed 115
percent of its income for such fiscal year, and
(iv) make arrangements with physicians or other health professionals,
health care institutions, or any combination of such individuals or institutions to
assume all or part of the financial risk on a prospective basis for the provision of basic
health services by the physicians or other health professionals or through the
institutions.
(E) The entity has made adequate provision against the risk of insolvency,
which provision is satisfactory to the Secretary.
Paragraph (2)(A)(ii) shall not apply to an entity which had contracted with a sin-
gle State agency administering a State plan approved under title XIX [42 U.S.C.S.
§ 1396 et seq.] for the provision of services (other than inpatient hospital services) to
individuals eligible for such services under such State plan on a prepaid risk basis
prior to 1970.
But see § 475 1(a), 104 Stat. at 1388-205, which does not require the states to supervise "eligible
organizations."
62. § 4206(a), 104 Stat. at 1388-115.
63. Id.
64. Id.
65. Id. at 1388-115 to -116.
66. Id. at 1388-116.
67. Id. at 1388-115.
68. § 4206(b), 104 Stat. at 1388-116. In reality, "providers need to be 'substantially out of
compliance' with the conditions of participation before action to exclude them will be taken."
Living Wills Hearings, supra note 9, at 116 (statement of Rep. Levin).
69. § 4751(d)(1), 104 Stat. 1388-205; § 4206, 104 Stat. 1388-115.
70. Id.
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health care organizations,7" aiding in the development of state law descrip-
tions,72 and assisting states in ensuring that health care providers receive
copies.73
III. OPPOSITION TO THE PSDA
The PSDA fails to address all the potential problems that might arise
through its mandates. For instance, critics argue that the PSDA cannot ef-
fectively achieve its goals of increasing the public's use and awareness of
advance directives. 74 The PSDA is criticized as being too weak;71 some ar-
gue that state law summaries cannot be written in a coherent and complete
manner 76 and that health care providers are not the optimal disseminators
of information about advance directives. 7
One of the PSDA's principal weaknesses stems from the fact that it was
enacted in abbreviated form with many of its original mandates either inten-
tionally or involuntarily deleted. For instance, the PSDA does not require
health care providers to create ethics committees; however, the original ver-
sion of the PSDA contained this requirement. 7' Ethics committees serve to
diffuse professional responsibility in health care decision-making. 79 These
committees have been the subject of debate,8 ° including the question of
whether they are actually effective and if mandating their use would be ap-
propriate."1 To facilitate passage, there are indications that the ethics com-
71. § 4751(d)(2), 104 Stat. 1388-205.
72. § 4751(d)(3), 104 Stat. 1388-205.
73. Id. at 1388-205 to -206.
74. See infra notes 78-113 and accompanying text.
75. See infra notes 78-89 and accompanying text.
76. See infra notes 90-95 and accompanying text.
77. See infra notes 98-113 and accompanying text.
78. See Diane E. Hoffmann, Regulating Ethics Committees in Health Care Institutions-Is
It Time?, 50 MD. L. REV. 746, 749-7 54 (1991) (discussing the historical role of ethics commit-
tees in the PSDA). See generally Symposium, Hospital Ethics Committees and the Law, 50
MD. L. REV. 742 (1991) (discussing the functions and usefulness of ethics committees and
ethics committee legislation).
79. In re Quinlan, 355 A.2d 647, 668-69 (N.J. 1976), cert. denied, 429 U.S. 922 (1976).
Relying on an article by Dr. Karen Teel, the New Jersey Supreme Court found that ethics
committees help screen out cases "which might be contaminated by less than worthy motiva-
tions of family or physician." Id. at 669; See Dr. Karen Teel, The Physician's Dilemma: A
Doctor's View: What the Law Should Be, 27 BAYLOR L. REV. 6, 8-9 (1975).
80. Compare John C. Fletcher, The Patient Self-Determination Act: Yes, HASTINGS
CENTER REP., Sept.-Oct. 1990, at 33, 33-35 (endorsing the PSDA for upholding advance di-
rective legislation) with Alexander M. Capron, The Patient Self-Determination Act: Not Now,
HASTINGS CENTER REP., Sept.-Oct. 1990, at 35, 35 (1990) (discussing how the PSDA fails to
reduce barriers to the use of advance directives).
81. Living Wills Hearings, supra note 9, at 122-23 (statement of Paul C. Rettig, Executive
Vice President, American Hospital Association). See generally George P. Smith, II, The Eth-
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mittee provision was replaced during "mark-up" sessions with the national
educational campaign mandate.8 2 However, many medical institutions have
created committees to protect the interests of patients, especially those who
are incapacitated. 3
Further, critics argue that the PSDA's designated means of enforcement
(loss of Medicare and Medicaid funding) has proven to be ineffective.8 4 One
commentator notes that the only likely consequence of this penalty is "a
great deal of resentment on the part of physicians and hospital personnel,
along with more trips to the courthouse induced by fear of liability."8 5  The
penalty's effectiveness is further stymied by the fact that additional funding
has not been provided to the DHHS or the states to monitor compliance
with the PSDA.8 6 While problems like these cannot be readily dismissed,
and admittedly weaken the PSDA, a stronger bill that allocated specific
funds may not have received the necessary support to pass congressional
scrutiny.87 However, if criticism increases, supplemental bills can be intro-
duced to Congress.8 8 Furthermore, if an evaluation determines that the law
is not adequately furthering its stated objectives, the PSDA can be
amended.8 9
In addition to complaints about the PSDA's inherent inability to address
all issues and its failure to create effective methods of enforcement, critics
also charge that states are incapable of writing adequate summaries of their
ics of Ethics Committees, 6 J. CONTEMP. HEALTH L. & POL'Y 157, 162-67 (1990) (discussing
the models for ethical decision-making that have been suggested as operational frameworks
through which ethics committees may act).
82. Cynthia B. Cohen, 1990 and Beyond: The Genie Out of the Bottle?, HASTINGS
CENTER REP., Sept.-Oct. 1990, at 33 (1990). For a discussion of the educational requirement,
see supra notes 69-73 and accompanying text.
83. Hoffmann, supra note 78, at 747.
84. See, e.g., Capron, supra note 80, at 35 (stating that the three sets of "Baby Doe"
Regulations have had no beneficial effect despite threats to cut off aid). See also Living Wills
Hearings, supra note 9, at 10-16 (statement of Hon. Gail R. Wilensky, Ph.D.). Dr. Wilensky,
Administrator of the Health Care Financing Administration, argues that Medicare and Medi-
caid restrictions should only be placed on conditions that are immediately and directly related
to the quality of health care because the effects of termination are so severe. Id. at 13.
85. Capron, supra note 80, at 35.
86. A.B.A. COMMISSION, supra note 2, at 3.
87. In fact, a more compelling bill did not get the necessary support to pass. See, e.g.,
H.R. CONF. REP. No. 1037, 101st Cong., 2nd Sess. 774-78 (1990), reprinted in 6
U.S.C.C.A.N., 194 Stat. 2479, 2479-83 (1990).
88. For a description of legislative procedure, see generally AMERICAN SOC'Y OF LEGIS-
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laws.' Many critics claim that the language of the state laws is often too
ambiguous to provide clear guidelines.91 States have also failed to establish
clear judicial opinions or statutes concerning the important issue of self-de-
termination.92 Still other states have neither legislation nor judicial opinions
addressing advance directives. 93 Further, states cannot predict the impact of
Cruzan on their laws until judicial action or legislative initiative clarifies the
issues. 94 Additionally, a conflict of laws issue may arise because states rarely
address the concerns of patients who have executed advance directives
outside the health care provider's home state.95
These problems are not insurmountable, and the state law guidelines can
always be revised to correct deficiencies. Furthermore, enactment of ad-
vance directive legislation significantly increased in the past five years, and
these laws have been refined. 96 Thus, it is expected that the state guidelines
will become more clear and therefore more effective. However, the threat of
removing Medicare and Medicaid funding will prove ineffective if the states
or federal government fail to authorize funding for monitoring compliance.97
Generally, critics also argue that health care providers are improper and
ineffective disseminators of advance directive information for several rea-
sons. First, the PSDA might reassign the role of advocating advance direc-
tives from doctors to other health care providers.9" In truth, physicians still
90. William Booth, U.S. "Living Will" Rule Creates Confusion, WASH. POST, July 17,
1991, at Al.
91. Id.; see, A.B.A. COMMISSION, supra note 2, at 2; see also Kelly C. Mulholland, Re-
cent Developments, Protecting the Right To Die: The Patient Self-Determination Act of 1990,
28 HARV. J. ON LEGIS. 609, 627-628 (1991) (discussing several procedural shortcomings of
PSDA).
92. In fact, "[a]mbiguities and uncertainties arise in virtually every state's law, even in
those states with quite detailed advance directive statutes." A.B.A. COMMISSION, supra note
2, at 2.
93. For a list of states that have enacted legislation regarding advance directives, see supra
note 57.
94. See A.B.A. COMMISSION, supra note 2, at 7-8.
95. Living Wills Hearings, supra note 9, at 125-26 (statement of Charles P. Sabatino, As-
sociate Director of the American Bar Association's Commission on Legal Problems of the
Elderly).
96. At one point, state legislatures enacted health care power of attorney acts on average
of one per month. See id. (citing 20 health care power of attorney acts passed through state
legislatures from February 1989 through July 1990).
97. U.S. DEP'T OF HEALTH AND HUMAN SERVS., STATE MEDICAID MANUAL § 2-82.36
(1991) (allowing for federal reimbursement for 50% of the administrative costs of the develop-
ment and distribution of information).
98. See Reconciliation Issues Hearing, supra note 3, at 179 (statement of Concern By Dy-
ing and The Society for the Right to Die).
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play an essential role in advance directive decision-making. 99 However, re-
cent studies demonstrate that, while theoretically physicians are viewed as
the most effective disseminators of information about advance directives be-
cause of the unique doctor/patient relationship, in practice, they have failed
in their duty to inform patients of advance directives because they deem
them to be a patient's responsibility." °° In addition, physicians often lack
sufficient understanding of the laws which precludes them from providing an
informed opinion.' 0 ' In many instances, physicians are reluctant to intro-
duce the topic because they fear the patient's reaction."0 2
Second, fears exist that the advance directive information disseminated to
the patients will prove confusing especially if accompanied by complicated,
perhaps intimidating,'0 3 bureaucratic forms. ' 4 In most instances, the staff
member disseminating the information may not be able to answer questions
pertaining to the forms.' 05 To prevent this problem, it is imperative that
health care providers inform all their employees, not just admission clerks,
about the requirements of the PSDA.' °6 Further, the PSDA's mandate of
continuing education on issues concerning advance directives can prevent
this problem.'0 7
Third, health care provider liability might increase under the PSDA. 08
For example, hospitals have not been given guidelines on how to effectively
99. Id.; see also Capron, supra note 80, at 35. The American Bar Association Commission
on Legal Problems of the Elderly notes that:
Physicians play the central role in promoting understanding of one's condition, situa-
tions that are likely to arise, and the pros and cons of options available for care and
treatment.... If the physician does not fully understand or has moral objections to
instructions given in one's advance directive, the directive's impact will be impaired
or undermined altogether.
A.B.A. COMMISSION, supra note 2, at 25.
100. La Puma et al., supra note 3, at 402-03.
101. 136 CONG. REC., supra note 26, at E943, E944 (statement of Rep. Levin) (citing a
Colorado survey which found that 23% of doctors are not familiar with living wills, and 74%
are not familiar with durable powers of attorney).
102. Id.; see also Paul Cotton, Providers to Advise of 'Medical Miranda" 265 JAMA 306,
306 (1991) (finding that physicians are unaware of how to talk to patients about the issue).
One doctor noted, "I'd rather shoot myself in the foot than start a living will discussion."
Lewin, supra note 7, at AI3.
103. See Terese Hudson, Hospitals Work To Provide Advance Directives Information,
Hosp., Feb. 5, 1990, at 26, 32 (1991).
104. See La Puma et al., supra note 3, at 403.
105. See Capron, supra note 80, at 35.
106. See Cotton, supra note 102, at 306.
107. See § 4206(a)(2)(E), 104 Stat. 1388-116 (1990).
108. Hudson, supra note 103, at 32.
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convey information on advance directives to illiterate patients °9 or patients
who enter hospitals in an emergency condition. 110 Indeed, institutions
might implement improper policies, and patients might misread or misun-
derstand forms.' Should patients and their families attempt to impose lia-
bility on health care providers who fail to follow institutional policies
regarding advance directives, the PSDA might serve as the standard for de-
termining whether the policies adequately reflect the duty of disclosure." 2
The potential that health care provider liability may increase may be consid-
ered a positive consequence of the PSDA if it leads to greater internal moni-
toring by institutions. This increased internal monitoring serves to offset the
states' obligation to conduct external supervision to ensure compliance with
the PSDA's requirements.1 13
III. AN ARGUMENT IN SUPPORT OF THE PSDA
Prior to the PSDA, the media, through informational articles and cover-
age of high profile cases, increased the public's awareness about advance di-
rectives. 4 The PSDA represents a legislative effort to ensure that the
disseminated information is reliable and applicable in the state in which a
reader resides. By contributing to this flow of information, the federal gov-
ernment benefits the people both individually and collectively. In an individ-
ual capacity, it promotes a person's right to choose to end his life; in a
collective capacity, it promotes the public's rights by decreasing wasted re-
sources that result from unwanted and unnecessary medical treatment.
The PSDA attempts to return the right of self-determination to the pa-
tient. 15 As life sustaining medical technology has increased, this right
seems to have slowly moved away from the individual into the hands of third
party decision-makers. 1 6 These third-party-players cannot truly act on be-
half of the patients' best interests if those interests are unknown. The roles
109. See La Puma et al., supra note 3, at 404. "Even well-educated patients may find it
difficult to understand the terms and conditions of such plans." Id. at 403.
110. See Mulholland, supra note 91, at 628.
111. See Hudson, supra note 103, at 26.
112. See La Puma et al., supra note 3, at 404.
113. § 4206(a)(2), 104 Stat. 1388-115 to -116.
114. High profile media coverage of the Cruzan case demonstrates how the media has in-
creased public awareness about advance directives. See, e.g., Jackie Fitzpatrick, Volunteer
Lawyers Visit the Elderly As Interest in Living Wills Grows, N.Y. TIMES, Oct. 21, 1990, at
CN12 (Conn. ed.).
115. Living Wills Hearings, supra note 9, at 6 (statement of Rep. Levin).
116. One commentator noted:
[I]n all too many other cases, the patient and the physician, the primary care giver
with that patient and the patient's family have frequently been in agreement, but
some other entity has been intruded. It might be a hospital employee; it might be a
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played by patients and their families in deciding on medical treatment,
although deeply rooted in tradition,1 17 has deteriorated over the past half
century.118 Because of the lack of uniform communication mechanisms that
identify patient values and wishes, patients have lost their ability to commu-
nicate their health care decisions. 119
While deemed to be a buffer in these decisions, the third party in reality
may make decisions which do not accurately reflect the interests of the indi-
vidual patients."2 In New Jersey, for example, the politically appointed
Nursing Home Ombudsman serves as the surrogate decision-maker for all
nursing home residents who have reached the age of sixty, and who have
not, while competent, chosen to withdraw or withhold life-sustaining treat-
ment.121 In limited cases in which the resident is in a persistent vegetative
state, the Ombudsman, entering each case without any prior knowledge
about the resident, has the authority to disregard the wishes of family mem-
bers and the attending physicians and refuse to allow the withdrawal of life-
sustaining treatment.' 2 2 By disseminating information about advance direc-
tives, the PSDA attempts to take this decision-making role away from the
third party and ensure that the decisions uphold the interests of the patient,
the families, and the physicians in each case.
Additionally, the PSDA attempts to minimize the costs of unwanted and
unnecessary care.123 Although these costs are assessed in both monetary
and nonmonetary terms, the PSDA is, among other things, a cost contain-
ment measure.124 With the expected increase in advance directives, the
PSDA can help reduce federal Medicare payments to health care providers,
hospital institution itself; it might even be some person who appears to have no busi-
ness in the case and it ends up in a court room.
Id. at 43 (statement of Dr. Nancy W. Dickey).
117. John Hardwig, What About the Family?, HASTINGS CENTER REP., Mar.-Apr. 1990,
at 5, 5 (1990) (discussing how patient autonomy ignores family interests in medical treatment
decisions).
118. 135 CONG. REC. S13,566, 13,571 (daily ed. Oct. 17, 1989) (statement of Father Den-
nis Brodeur). Father Brodeur blames the erosion on advanced age, emotional strains and fam-
ily life, as well as "the technological imperative that is a part of medicine, and... the fear of
legal action on the part of providers and health care institutions." Id.
119. Id.
120. See generally AMERICAN JEWISH CONGRESS BIo-ETHICS TASK FORCE, SUBSTITUTE
MEDICAL DECISION-MAKING FOR PATIENTS WHO LACK CAPACITY 4-8 (May 5, 1991).
121. See generally N.J. ADMIN. CODE tit. 5, § 100-2.3 to -2.5 (Supp. 1990).
122. Id. N.J. ADMIN. CODE tit. 5, § 100-2.4(g) gives the Nursing Home Ombudsman dis-
cretion to decide whether or not to defer to the judgment of two doctors, the attending physi-
cian, and at times, a family member.
123. La Puma et al., supra note 3, at 404.
124. Id.; see also Margot L. White & John C. Fletcher, The Patient Self-Determination Act:
On Balance, More Help Than Hindrance, 266 JAMA 410 (1991) (discussing the historical
perspective of congressional implementation of cost containment measures).
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assuming that the directives stipulate a limit on providing life prolonging
treatment.125 The potential of this limitation is significant; of the six percent
of Medicare enrollees who die annually, their care consumes twenty-eight
percent of annual Medicare expenses. 126 This amount is expected to in-
crease dramatically as the baby boom generation ages. 127
Yet, assuming that patients elect to limit expensive procedures to prolong
life, nonmonetary costs, including the emotional strain of watching a family
member or friend exist solely through the use of a feeding tube or respirator,
can be avoided. 128 On a broader scale, the resources saved by federal or
private insurers can be allocated to patients who can survive without ma-
chinery, and these savings might be reflected in the costs of health care in-
surance premiums. 129 Increasing the use of advance directives would also
eliminate the need for expensive court battles over a patient's rights. 3
CONCLUSION
The effectiveness of the PSDA will be proven only with time. Presently,
critics and supporters may only speculate about its potential failure or suc-
cess. Indeed, even if there is a significant increase in the use of advance
directives, whether that increase will be directly linked to the PSDA remains
unclear. The PSDA, despite its faults, clearly states its objectives. Individu-
als have a right to autonomy; they have a right to choose their destiny.
While it may take time to eliminate the statute's ambiguities, the PSDA rep-
125. See, for example, the facts surrounding the Cruzan dilemma in which the state of
Missouri paid $130,000 a year to maintain Nancy Cruzan. Susan Okie, Medical Groups Criti-
cize Court for Interfering in Life-or-Death Decisions, WASH. PosT, June 26, 1990, at A8.
126. La Puma et al., supra note 3, at 404 ("[M]any patients--especially the elderly-will
opt to limit the expensive, intensive treatment that they may receive in hospitals.").
127. PETER J. STRAUSS ET AL., AGING AND THE LAW 488 (1990).
128. See, e.g., Living Wills Hearings, supra note 9, at 117 (statement of Richard A. McCor-
mick, S.J.) (discussing examples of problems that arise when a patient fails to execute an ad-
vance directive).
129. See generally, Edmund D. Pellegrino, Rationing Health Care: The Ethics of Medical
Gatekeeping, 2 J. CONTEMP. HEALTH L. & POL'Y 23 (1986) (discussing how costs can be cut
by eliminating "unnecessary" medical care).
130. 135 CONG. REC. 13,566 (daily ed. Oct. 17, 1989) (statement of Sen. Danforth).
"[W]ithout any clear directive from a patient, the fear of liability and malpractice suits some-
times causes doctors to refuse the termination of treatment, even when the family says the
medical intervention is the last thing in the world that their loved one would have wanted."
Id. This refusal can often lead to a lawsuit. Id. at 13,567. But see Hudson, supra note 103, at
32 (discussing the potential increase in courtroom battles because of increased hospital liabil-
ity; the cases may involve a preemption of future challenges from the state).
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resents an essential step by the federal government towards upholding this
right.
Michael A. Refolo

